The report concludes with strategic implications: how pharma teams can leverage metrics (see Table 2 below) and initiatives (ePA, patient assistance, data analytics) to improve GLP-1 therapy uptake, and how emerging trends (new drugs, regulatory changes, alternate channels) may reshape access in coming years
If the GOAT wasnt okay with her body, how were the rest of us supposed to be okay with ours
While some patients experience diarrhea, most find the opposite, with slowed gastric emptying producing slower movement throughout the digestive system
Dulaglutide (Trulicity) begins at 0.75 mg once weekly, with potential increases to 1.5 mg, 3 mg, or a maximum of 4.5 mg weekly based on glycemic response
Patients should also ask which ingredient form is being used, as some compounded products may use salt forms that differ from FDA-approved formulations
Track which ones sell out first, generate repeat purchases, and spark questions